TXG - 10x Genomics, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$22.43
DETAILS
HIGH:
$30.00
LOW:
$17.00
MEDIAN:
$22.00
CONSENSUS:
$22.43
DOWNSIDE:
5.28%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 69.1% |
| EBIT Margin | -17.2% |
| EBITDA Margin | -17.2% |
| Operating Margin | -17.2% |
| Pretax Margin | -6.2% |
| Cont. Ops Margin | -6.8% |
| Net Margin | -6.8% |
| Bottom Line Margin | -6.8% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 4.46 |
| Quick Ratio | 4.09 |
| Solvency Ratio | -0.178 |
| Cash Ratio | 3.09 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-46.73
Peers avg: 44.4
|
| PEG Ratio | 0.61 |
| Forward PEG | 0.61 |
| Price/Book | 2.56 |
| Price/Sales | 3.17 |
| Price/FCF | 15.64 |
| Price/Op Cash Flow | 14.96 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.1515 |
| Debt/Equity | 0.1981 |
| Debt/Capital | 0.1653 |
| Long-Term Debt/Capital | 0.0844 |
| Financial Leverage | 1.31 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 1.29 |
| Operating Cash Flow Ratio | 0.887 |
| Operating Cash Flow/Sales | 21.2% |
| Free Cash Flow/Operating Cash Flow | 95.6% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -10.43 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | 12.39 |
| Operating Cash Flow Coverage | 0.86 |
| Capital Expenditure Coverage | 22.92 |
| Dividend + Capital Expenditure Coverage | 22.92 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 5.15 |
| EPS | -0.349 |
| Debt/Share | 1.2644 |
| Cash/Share | 4.20 |
| Book Value/Share | 6.38 |
| Tangible BV/Share | 5.85 |
| Equity/Share | 6.38 |
| Operating Cash Flow/Share | 1.091 |
| Capital Expenditure/Share | 0.048 |
| FCF/Share | 1.043 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.091 |
| Earnings Before Tax/EBIT | 0.360 |
| Price/Fair Value | 2.56 |
| Debt/Market Cap | 0.0415 |
| Effective Tax Rate | -9.1% |
| Enterprise Value Multiple | -15.50 |